Carisoprodol Tablet
Product Images NDC 69367-420

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Carisoprodol (NDC 69367-420). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Westminster Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Carisoprodal 01)

Chemical Structure (Carisoprodal 01)
Chemical structure diagram of the active ingredient Carisoprodol, showing its molecular framework including amide and ester functional groups.*
FDA Label Image

Principal Display Panel (250 mg Tablet Bottle Label)

Principal Display Panel (250 mg Tablet Bottle Label)
Label for Carisoprodol Tablets USP 250 mg oral tablets, provided by Westminster Pharmaceuticals. The label includes the dosage strength (250 mg), quantity (100 tablets), and indicates the product is classified as Schedule IV (CIV). It also shows the NDC number 69367-419-01, storage instructions, and manufacturing details for MPP Pharma, LLC.*
FDA Label Image

Principal Display Panel (350 mg Tablet Bottle Label)

Principal Display Panel (350 mg Tablet Bottle Label)
The label for Carisoprodol Tablets, USP 350 mg by Westminster Pharmaceuticals, LLC shows the dosage strength prominently in pink. It states each tablet contains 350 mg of Carisoprodol and is an oral tablet with a package size of 100 tablets. The label includes storage instructions, an NDC number 69367-420-01, the controlled substance classification (C IV), and manufacturer information for Westminster Pharmaceuticals.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.